Hepatic stellate cell-specific Kcnma1 deletion mitigates metabolic dysfunction-associated steatotic liver disease progression via upregulating Amphiregulin secretion
Authors:
Open Access
- 9 May 2025
- journal article
- Published by Elsevier in Molecular Metabolism
- Vol. 97, 102164
Abstract
No abstract availableKeywords
Funding Information
- Shanghai Municipal Natural Science Foundation (23ZR1458200)
- Shanghai Jiao Tong University (YG2022QN117, YG2022QN116)
- National Key Research and Development Program of China (2021YFC2701900)
- National Natural Science Foundation of China (82070634, 82300971, 82002495)
This publication has 55 references indexed in Scilit:
- Dissociating fatty liver and diabetesTrends in Endocrinology & Metabolism, 2013
- A novel murine model to deplete hepatic stellate cells uncovers their role in amplifying liver damage in miceHepatology, 2012
- Genome wide association study identifies KCNMA1contributing to human obesityBMC Medical Genomics, 2011
- Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score and the Histopathologic Diagnosis in NAFLD: Distinct Clinicopathologic Meanings §ΔHepatology, 2010
- Large‐conductance calcium‐activated potassium channels modulate vascular tone in experimental cirrhosisLiver International, 2008
- Substrate Selectivity of Epidermal Growth Factor-Receptor Ligand Sheddases and their Regulation by Phorbol Esters and Calcium InfluxMolecular Biology of the Cell, 2007
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- Novel Role for Amphiregulin in Protection from Liver InjuryJournal of Biological Chemistry, 2005
- Human myofibroblastic hepatic stellate cells express Ca2+-activated K+ channels that modulate the effects of endothelin-1 and nitric oxideJournal of Hepatology, 2001
- Liver RegenerationScience, 1997